Abstract
Viele Untersuchungen weisen einen schlechteren Gesundheitszustand von Männern im Vergleich zu Frauen nach. Die kürzere Lebenserwartung von über 6 Jahren ist nur ein Indikator dieser Tatsache. Es verwundert, wie wenig diese geschlechtsspezifischen Unterschiede zum Nachteil vor allem des alternden Mannes ein Thema in der Gesundheitsversorgung darstellen. In diesem Zusammenhang stellen wir einige ausgewählte urologische Probleme des alternden Mannes wie die benigne Prostatahyperplasie, das Prostatakarzinom und die erektile Dysfunktion kurz dar. Viele neue Entwicklungen lassen bei diesen Erkrankungen eine Verbesserung der männlichen Gesundheit erwarten. Hierzu ist es auch notwendig, daß die gesundheitliche Versorgung älterer Menschen ein öffentliches Anliegen wird, welches neben medizinischen Problemen auch Fragen zur Lebensqualität einschließt. Die Breite von unterschiedlichen urologischen Problemen zeigt die Komplexität bei der Versorgung alternder Männer. Eine geschlechtsspezifische, fachübergreifende Forschung ist notwendig. Hiervon profitieren nicht nur alternde Männer, sondern beide Geschlechter.
Introduction: The Silent Crisis of Male Aging
While women’s health—particularly regarding menopause—has gained substantial clinical and social attention, the "aging male" has historically remained a neglected demographic. This disparity is starkly illustrated by the fact that men live, on average, six years less than women. This gap is driven by a combination of biological factors and a lack of gender-specific medical focus.
As the global population ages, with 15% expected to be over 65 by 2050, there is an urgent need to recognize "men’s health" as a distinct clinical field. The urologist must evolve into a "Männerarzt" (a male equivalent to a gynecologist) to manage the complex interplay of hormonal changes, fertility, and sexual function that define the male aging process.
Key Urological Challenges
Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia is a nearly universal condition of the aging male, with approximately 70% of men over 60 showing symptomatic prostate enlargement. While the "Gold Standard" treatment has long been Transurethral Resection of the Prostate (TUR-P), the field is shifting toward minimally invasive alternatives, such as laser therapy and focused ultrasound, to improve patient recovery and quality of life.
Prostate Cancer: The Occult Malignancy
Prostate cancer ranks as the second most common malignancy in men, with incidence rising by 3–8% annually. A striking statistic noted in the research is that over 30% of men over 60 harbor "occult" (hidden) prostate cancer. This highlights the diagnostic challenge of differentiating between slow-growing, low-malignancy tumors and aggressive ones. Furthermore, the disease's absolute dependence on male hormones—evidenced by the fact that eunuchs do not develop prostate cancer—remains a cornerstone of palliative hormone-deprivation therapies.
Erectile Dysfunction: From Psychology to Physiology
One of the most significant paradigm shifts in urology concerns erectile dysfunction (ED). Historically, 80% of ED cases were attributed to psychological factors like performance anxiety. However, multidisciplinary diagnostics now reveal that 85% of cases have multiple causes, with over 60% being primarily organic (e.g., vascular damage or diabetes).
Data from the Cologne 8000-Survey demonstrates that ED is heavily age-dependent. While the total prevalence across men aged 30–80 is approximately 15%, this figure skyrockets in older cohorts.
The introduction of PDE5 inhibitors has marked a transition toward effective, non-invasive therapy, providing relief in over 60% of cases and significantly improving the "Lebensqualität" (quality of life) for both the patient and their partner.
Conclusion and Future Directions
Urological health is not merely a matter of mortality; it is a matter of self-esteem and quality of life. The current "economization of medicine" poses a risk to individualized care, yet the need for sex-specific, interdisciplinary research has never been greater. Addressing the urological problems of the aging man is a public health necessity that benefits society as a whole.
Reference: Klotz T, Sommer F. Urologische Probleme des alternden Mannes. J. Menopause 2001; 8 (2): 35–38.
Summary updated